Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients

@article{Hojs2016MarkersOI,
  title={Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients},
  author={R. Hojs and R. Ekart and S. Bevc and Nina Hojs},
  journal={Nephron},
  year={2016},
  volume={133},
  pages={159 - 162}
}
  • R. Hojs, R. Ekart, +1 author Nina Hojs
  • Published 2016
  • Medicine
  • Nephron
  • The prevalence of diabetes is increasing and has already reached pandemic proportions. Diabetes is a well-known risk factor for chronic kidney disease. Diabetic kidney disease (DKD) occurs in up to 40% of people with type 1 or 2 diabetes and is nowadays the leading cause of end-stage renal disease (ESRD). Among several factors involved in the development and progression of DKD are also inflammation and oxidative stress. Unfortunately, there is a paucity of sensitive and specific biomarkers for… CONTINUE READING
    28 Citations
    Inflammatory Targets in Diabetic Nephropathy
    • 11
    • PDF
    Renal expression of cytokines and chemokines in diabetic nephropathy
    • 1
    Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
    • O. Oguntibeju
    • Medicine
    • International journal of physiology, pathophysiology and pharmacology
    • 2019
    • 74
    Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
    • 25
    • PDF
    The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease
    • 3
    • PDF
    The Promise of Systems Biology for Diabetic Kidney Disease.
    • 5

    References

    SHOWING 1-10 OF 22 REFERENCES
    Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
    • 275
    • PDF
    Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
    • 216
    • PDF
    Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.
    • 212
    Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.
    • 112
    • PDF